They work through complementary mechanisms
Studies have shown that Epithalon treatment can increase telomerase activity measured by the TRAP assay in cultured human cells, correlating with measurable telomere elongation
This reflects their different mechanisms
Due to the key role of BBB dysfunction in neuronal diseases, protection of brain endothelial cells became a therapeutic target in brain pathologies [11]
Moreover, in chickens, OTA and viruses responsible for inclusion body hepatitis acted synergistically to aggravate chicken anemia (105)
[13] Orally ingested compounds first pass through the gastrointestinal tract and gut microbiome where some xenobiotics can be metabolized before entering the bloodstream, while inhaled, intravenous, or dermal exposures enter circulation more directly